Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

This will play a video. - woman swimming

Transcatheter Aortic Heart Valve Replacement

From a design built on a proven platform¹, the Evolut™ PRO+ system provides the performance and outcomes you need to help patients live life to the fullest.

pdf SMART Trial TAVI (.pdf) (opens new window)

477KB

(opens new window)

pdf Discover the advantages of the Evolut™ FX system implant procedure (.pdf) (opens new window)

1.7MB

(opens new window)

pdf Download late-breaking clinical evidence: (.pdf) (opens new window)

4 Years outcome from the Evolut™ Low Risk Trial

1.4MB

(opens new window)

pdf Download CoreValve™ TAVI Trial 10 Year Data (.pdf) (opens new window)

2.3MB

(opens new window)

pdf Evolut™ Low Risk 3 Years Trial (.pdf) (opens new window)

365KB

(opens new window)

pdf Echocardiography Guide (.pdf) (opens new window)

1.6MB

(opens new window)

Evolut PRO+ system

Built upon the proven Evolut platform, the Evolut PRO+ system offers the lowest delivery profile for 23-29 mm valves, excellent hemodynamics, the broadest annulus range,* and advanced sealing with an external tissue wrap.

See the Evolut PRO+ system

Beauty shot of the Evolut Pro+ system heart valve

Evolut™ first

Download the brochure (opens new window)

Leading Hemodynamics

Designed for large EOAs, low gradients, and minimal patient prosthesis mismatch, the Evolut TAV allows your patient to return to activity faster.^†

See the data

Evolut Pro 29mm

References

Data on file (>20 clinical trials with over 20000 patients enrolled).

Broadest annulus range based on CT derived diameters.

^†

Popma JJ. SURTAVI: Two Year Complete Results from a Randomized Trial of a Self-expanding Transcatheter Heart Valve vs. Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk. Presented at TCT 2018; San Diego, CA.